Title : Risk of retinal vein occlusions in patients treated with rofecoxib (vioxx).

Pub. Date : 2005 Jul-Aug

PMID : 16088245






2 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 AIMS: To present patients with branch retinal vein occlusion (BRVO) and central retinal vein occlusion (CRVO) after application of rofecoxib (Vioxx), a cyclo-oxygenase (COX) 2 inhibitor. rofecoxib mitochondrially encoded cytochrome c oxidase II Homo sapiens
2 AIMS: To present patients with branch retinal vein occlusion (BRVO) and central retinal vein occlusion (CRVO) after application of rofecoxib (Vioxx), a cyclo-oxygenase (COX) 2 inhibitor. rofecoxib mitochondrially encoded cytochrome c oxidase II Homo sapiens